Provision of Wigs Policy

Similar documents
Other (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications

Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications

Animals and Pets in Healthcare Facilities Policy

Outbreak Control Policy

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

Diagnostic Testing Procedures in Neurophysiology V1.0

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.

Tissue Viability Referral Pathway. April 2017

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline

Diagnostic Testing Procedures for Ophthalmic Science

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.

Discharge and Transfer Policy

Access to Health Records Procedure

CCG CO21 Continuing Healthcare Policy on the Commissioning of Care

Policy on Governance Arrangements Relating to Medicines V2.0

Aseptic Technique Policy

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline

Diagnostic Testing Procedures in Urodynamics V3.0

Loading Dose Worksheet for Oral Amiodarone

Document Title: Training Records. Document Number: SOP 004

GCP Training for Research Staff. Document Number: 005

MOVING TO ALTERNATIVE PREMISES (SERVICE/TEAM/STAFF) POLICY

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Central Alerting System (CAS) Policy

Version Number Date Issued Review Date V1: 28/02/ /08/2014

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing

SAFEGUARDING CHILDEN POLICY. Policy Reference: Version: 1 Status: Approved

Medical Needs Policy. Policy Date: March 2017

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

Version: 2. Date adopted: 17 May publication: Review date: September Expiry date: March 2019

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Wig and Hair Replacement Policy

Document Title: Recruiting Process. Document Number: 011

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services

Safe Bathing Policy V1.3

Manual Handling Policy

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Title: File Notes. Document Number: 024

DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY

School Vision Screening Policy V2.0

Impact Assessment Policy. Document author Assured by Review cycle. 1. Introduction Policy Statement Purpose or Aim Scope...

Patient Experience Strategy

Document Title: Version Control of Study Documents. Document Number: 023

Hepatitis B Immunisation procedure SOP

SABP/INFORMATIONSECURITY- SUMMARY CARE RECORD ACCESS/0003

Escorting Patients Policy

Person/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729

Document Title: Investigator Site File. Document Number: 019

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE

your hospitals, your health, our priority CATHETERISATION Urethral/ supra-pubic POLICY NAME: VERSION NUMBER : 1 PROFESSIONAL ADVISORY BOARD (PAB)

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

Medical Devices Management Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage

Document Title: Research Database Application (ReDA) Document Number: 043

JOB DESCRIPTION. Specialist Nurse - Asthma (Paediatrics) Children s Specialist Community Nursing Service (CSCNS)

Visual Communication Alert Symbols Guidelines for Staff. Version 4.0. All Hospital Staff. Care Quality Commission s fundamental standards

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

Wandsworth CCG. Continuing Healthcare Commissioning Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care

Document Title: Research Database Application (ReDA) Document Number: 043

Moving and Handling Policy

DATA PROTECTION ACT (1998) SUBJECT ACCESS REQUEST PROCEDURE

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

CCG: CO01 Access and Choice Policy

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)

Contract of Employment

NON-MEDICAL PRESCRIBING POLICY

Document Title: Informed Consent for Research Studies

your hospitals, your health, our priority

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

Drainage of Abdominal Ascites

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives

Birmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT)

Policy for Overseas Visitors

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

EAST & NORTH HERTS, HERTS VALLEYS CCGS SAFEGUARDING CHILDREN & LOOKED AFTER CHILDREN TRAINING STRATEGY

ORAL ANTI-CANCER THERAPY POLICY

CO33: Policy for commissioning of a care provision within the continuing healthcare pathway

Version: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018

Barnet Health Overview and Scrutiny Committee 6 October 2016

Date 4 th September 2015 Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate Director of Quality Laura Rowe, Compliance Manager

HUMAN RESOURCES POLICY

Health Overview and Scrutiny Committee 6 July 2015

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite

Agenda Item: REPORT TO PUBLIC BOARD MEETING 31 May 2012

Document Title: Document Number:

Register No: Status: Public on ratification

Transcription:

Post holder responsible for Procedural Document Author and post holder of Policy Division/Department responsible for Procedural Document Contact details Lead Cancer Nurse Tina Grose, Lead Cancer Nurse Cancer Services x2896 Date of original policy 11/01/2013 Impact Assessment performed Yes/No Ratifying body and date ratified Senior Operational Group (SOG) 18/06/2014 Review date (and frequency of further reviews) 01/11/2016 (every 3 years) Expiry date 21/05/2017 Date document becomes live 03/09/2014 Please specify standard/criterion numbers and tick other boxes as appropriate Monitoring Information Strategic Directions Key Milestones Patient Experience Waiting Assurance Framework Privacy and Dignity Monitor/Finance/Performance Efficiency and Effectiveness CQC Regulations/Outcomes: Delivery of Care Closer to Home Infection Control Other (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications Controlled document This document has been created following the Royal Devon and Exeter NHS Foundation Trust Development, Ratification & Management of Procedural Documents Policy. It should not be altered in any way without the express permission of the author or their representative. Review date: November 2016 Page 1 of 14

Full History Version Date Author (Title not name) 1.0 11/01/2013 Health Records Manager Status: Final Reason To confirm patients entitlement to the provision of a wig appliance Associated Policies: Information Governance Policy Health Records Policy In consultation with and date: Cancer Patient Support Group: January 2013 Tina Grose, Lead Nurse Cancer Services: January 2013 and 06/03/2014 Patient Experience Group: 01/04/2014 Associate Director of Nursing: 06/03/2014 Governance Managers: 04/03/2014 Policy Expert Panel: 02/12/2013 Senior Operational Group 18/06/2014 Review Date 01/10/2016 Contact for Review: Tina Grose, Lead Cancer Nurse Executive Lead Signature: Chief Nurse Review date: November 2016 Page 2 of 14

CONTENTS 1. INTRODUCTION... 4 2. PURPOSE... 4 3. DEFINITIONS... 4 4. DUTIES AND RESPONSIBILITIES OF STAFF... 5 5. PATIENTS REQUIRING A WIG... 5 6. ACRYLIC WIGS... 6 7. REAL HAIR WIGS... 6 8. ARCHIVING ARRANGEMENTS... 7 9. PROCESS FOR MONITORING COMPLIANCE WITH AND EFFECTIVENESS OF THE POLICY... 7 10. REFERENCES... 8 11. ASSOCIATED TRUST POLICIES... 8 APPENDIX 1: WIG APPLIANCE PRESCRIPTION FORM... 9 APPENDIX 2: THE PROVISION OF WIGS INFORMATION LEAFLET... 10 APPENDIX 3: RAPID IMPACT ASSESSMENT SCREENING FORM... 12 Review date: November 2016 Page 3 of 14

1. INTRODUCTION 1.1 The NHS makes provision for the supply of wigs to people who need them in order to help with medical hair loss as a result of a condition or treatment. 1.2 The process of wig provision varies around the country. It is expected that Trusts will manage their wig provision within a budget. 1.3 The Department of Health leaflet HC11 Are you Entitled to Help with Health Costs, (DoH, 2012a) provides information on providing patients with a wig through the NHS. 1.4 Failure to comply with this policy could result in disciplinary action. 2. PURPOSE 2.1 The Royal Devon & Exeter NHS Foundation Trust (hereafter referred to as the Trust ) provides wigs to NHS patients receiving their NHS treatment at the Trust. 2.2 This policy is to ensure the fair and equitable provision of wigs to patients where they are needed in the course of treatment 2.3 The policy is for NHS patients who require a wig for temporary, long term and permanent hair loss. It does not include provision for patients who are being treated privately or by another NHS Provider for a condition that results in hair loss. 3. DEFINITIONS 3.1 Approved Wig Supplier wig suppliers under contract to the NHS through a framework agreement must supply a good standard of wig, offer choice along with a confidential and quality service. The suppliers are members of the Hairdressing and Beauty Suppliers Association and have subscribed to a code of conduct and practices which comply with British Standard ISO 9001. 3.2 Authorised Prescription Form the Trust s approved prescription form for a clinician to prescribe a wig appliance to a Trust patient receiving treatment at the Trust for a condition that results in temporary hair loss or where the patient has permanent hair loss. 3.3 Course of Treatment - a prescribed regime to be followed for a specific period of time. 3.4 National Set Prescription Charge the Department of Health (DoH) review the wig appliance prescription charge on an annual basis every April. This is currently set at 64.95 for an acrylic wig and 245.40 for a real hair wig as at January 2014. 3.5 For the purpose of this policy a Specialist Clinician is a consultant or senior nurse from Oncology, Haematology, Radiotherapy or Dermatology who treat patients with permanent or temporary hair loss as a medical condition or as a result of treatment they are receiving. Review date: November 2016 Page 4 of 14

4. DUTIES AND RESPONSIBILITIES OF STAFF 4.1 The Chief Nurse/Chief Operating Officer is the Executive Trust Board Officer who has overall responsibility for patient care and provides assurance to the Board on any risks associated with patient care. 4.2 The Lead Cancer Nurse is responsible for reviewing the policy and managing the budget for the provision of wigs to NHS patients prescribed a wig by the Trust. 4.3 The Appliance Officer is responsible for following the operating procedures to support the issuing of wigs to patients, keeping up to date records to ensure payment to suppliers is accurate. 4.4 Staff with a role in the implementation of this policy are responsible for ensuring they are familiar with and comply with the policy and their role in the implementation of the policy. This includes Oncology, Haematology, Radiotherapy and Dermatology Consultants, Senior Nurses, Matrons, Registered Nurses and the Force Cancer Charity. 4.5 The Senior Operational Group (SOG) is responsible for approving this policy. 5. PATIENTS REQUIRING A WIG 5.1 In order for a patient to receive a wig a prescription for a wig must be made by a specialist clinician. 5.2 All patients being prescribed a wig will pay a nationally set prescription charge, however, nationally set exemption criteria may apply to some patients who must complete a WF1 0403 form at: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/healthcare/entitlemen tsandcharges/nhscharges/dh_4049252 (DoH, 2010) and provide proof of continuing entitlement to benefits see HC11 Help with health costs at: http://www.nhs.uk/nhsengland/healthcosts/documents/2012/hc11-oct12- approved.pdf (DoH, 2012b) A person under 16 years of age 16-18 year olds in full time education Has a valid War Pension Exemption Certificate and the items prescribed are the accepted disablement Is named on a valid HC2 NHS low income scheme certificate Is named on a valid HC3 Certificate for help with health costs Get Income Support Gets Pension Credit guarantee credit * Gets income based Jobseeker s Allowance (JSA (IB)) Is entitled to, or named on, a valid NHS Tax Credit Exemption Certificate * Please note all pensioners will still be required to pay, as per government stipulations. Pensioners are not exempt. - Prescription charges are revised each April by the DoH. Review date: November 2016 Page 5 of 14

5.3 Patients will be offered a wig by the supplier of a suitable quality and within a specified price range. Where a patient chooses a wig within this range they will only pay the prescription charge unless they are exempt. 5.4 In order to give patients choice, patients may choose to have a wig outside the specified price range but will pay the difference in cost directly to the supplier. 5.5 All patients will be provided with an information leaflet and asked to complete a patient satisfaction questionnaire following the supply of a wig. 5.6 In order for the patient to make an informed choice on the wig and supplier, no order for a wig can be made by the Approved Supplier until the authorised Wig Appliance Prescription Form Appendix 1 has been received by the Appliance Officer. The Appliance Officer will then issue an order number to the Supplier. 5.7 An appointment may be made for the patient with the Supplier prior to receipt of the Prescription Form by the Appliance Officer but no order can be made or wig issued by the Supplier. 5.8 Wigs will only be supplied by companies on the Trust s list of approved wig suppliers Appendix 2. 6. ACRYLIC WIGS 6.1 The Trust will provide patients with an acrylic wig and will subsidise the cost up to 120 (inclusive of VAT) for each wig. 6.2 Patients experiencing temporary hair loss as a result of treatment they are receiving i.e. Chemotherapy/Radiotherapy, will receive one acrylic wig per course of treatment. If treatment exceeds a 7 month continuous period a second wig may be supplied. This will be reviewed further if treatment exceeds 15 months. 6.3 Patients experiencing permanent hair loss will be entitled to two acrylic wigs per year. 6.4 Only acrylic wigs will be supplied and no prescriptions will be accepted for a real hair wig. 7. REAL HAIR WIGS 7.1 There may exceptional circumstances where the consultant prescribes a real hair wig on the basis that the patient has a medical condition that excludes them from having an acrylic wig; or they are an existing patient with a prescription for a real hair wig. 7.2 The Trust will subsidise the cost of the real hair wig up to 500 (inclusive of VAT). The patient may choose a wig of a higher price and pay the difference directly to the supplier. 7.3 Where a real hair wig has been prescribed the patient will be entitled to receive one real hair wig per year or two every two years. 7.4 Patients with a real hair wig may have them cleaned and redressed on a monthly basis through the approved supplier, following the issue of an order number by the Appliance Officer in order for the invoice to be raised which will be paid for by the Trust. Review date: November 2016 Page 6 of 14

7.5 Where a patient is medically unfit to attend the Approved Supplier for the provision of a wig or for cleaning and redressing, the Trust will provide a Domiciliary visit by the Approved Supplier in a patient s home up to twice a year. 8. ARCHIVING ARRANGEMENTS The original of this policy will remain with the Lead Cancer Nurse in the Cancer Cluster. An electronic copy will be maintained on the Trust Intranet (IaN), P Policies W Wigs. Archived copies will be stored on the Trust s archived policies shared drive and will be held for 10 years. 9. PROCESS FOR MONITORING COMPLIANCE WITH AND EFFECTIVENESS OF THE POLICY 9.1 In order to monitor compliance with this policy, the auditable standards will be monitored as follows: No 1. 2. 3. Minimum Requirements Correct entitlement on the Issuing of Wigs to patients Correct number of wigs issued yearly against number of orders issues All patients will be provided with an information leaflet and asked to complete a patient satisfaction questionnaire following the supply of a wig. The Appliance Officer will process the questionnaires and forward any issues to the Lead Cancer Nurse who will contact the Supplier to address these. 4. Exemption criteria for prescription charge 5. Monthly Budget Reports Agresso Evidenced by Authorised Prescription Forms Invoices and Order Numbers Patient Satisfaction Questionnaire Copies of WF1 0403 form NHSLA standard 9.2 Frequency In each financial year, the Lead Cancer Nurse will audit the above to ensure that this policy has been adhered to and monitored through the Performance Assurance Framework meetings. 9.3 Undertaken by Lead Cancer Nurse 9.4 Dissemination of Results Through the Performance Assurance Framework. 9.5 Recommendations/ Action Plans Implementation of the recommendations and action plan will be monitored by the Performance Assurance Framework meetings. The Board reviews the Framework quarterly. 9.6 Any barriers to implementation will be risk-assessed and added to the risk register. Review date: November 2016 Page 7 of 14

9.7 Any changes in practice needed will be highlighted to Trust staff via the Governance Managers cascade system. 10. REFERENCES DoH (2012a). The Department of Health leaflet HC11 Are you Entitled to Help with Health Costs. London: Department of Health. Available at: http://www.nhs.uk/nhsengland/healthcosts/documents/2012/hc11-oct12- approved.pdf DoH (2010). Department of Health WF1 0403 form. Available at: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/healthcare/entitlemen tsandcharges/nhscharges/dh_4049252 DoH (2012b). HC11 Help with Health Costs. London: Department of Health. http://www.nhs.uk/nhsengland/healthcosts/documents/2012/hc11-oct12- approved.pdf The Hairdressing and Beauty Suppliers Association. Available at: http://www.thehbsa.co.uk/ British Standards Institution: British Standard ISO 9001 Available at: http://www.bsigroup.co.uk/en-gb/iso-9001-quality-management Veterans UK (undated). Pensions and Compensation - War Disablement Pensions. London: MOD. Available at: http://www.veterans-uk.info/pensions/wpd_question10.html NHS Choices (undated). NHS Low Income Scheme. (information on obtaining an HC2 NHS low income scheme certificate). Available at: http://www.nhs.uk/nhsengland/healthcosts/pages/nhs-low-income-scheme.aspx NHS Business Services Authority (2012). : Low Income Scheme - what you need to know (information on obtaining an HCS Certificate for help with health costs). NHS BSA. Available at: http://www.nhsbsa.nhs.uk/healthcosts/1136.aspx Wig Appliance Prescription form see: Appendix 1 11. ASSOCIATED TRUST POLICIES Information Governance Policy Health Records Policy Review date: November 2016 Page 8 of 14

APPENDIX 1: WIG APPLIANCE PRESCRIPTION FORM CONSULTANT:.. WIG APPLIANCE PRESCRIPTION FORM WARD/CLINIC: DIAGNOSIS: Is this patient receiving their treatment at the Royal Devon & Exeter Hospital? YES NO* (*IF NO, DO NOT COMPLETE THIS FORM PLEASE REFER THE PATIENT TO THE TREATMENT PROVIDER.) Will this treatment result in hair loss? YES NO PLEASE STATE REQUIREMENT: Is the patient exempt from paying the prescription charge? YES* NO (If Yes, copy of exemption must be provided and attached) AUTHORISED SIGNATURE:.. PRINT NAME:... DESIGNATION: DEPARTMENT:. DATE: DD/MM/YYYY... Review date: November 2016 Page 9 of 14

APPENDIX 2: THE PROVISION OF WIGS INFORMATION LEAFLET Review date: November 2016 Page 10 of 14

Review date: November 2016 Page 11 of 14

APPENDIX 3: RAPID IMPACT ASSESSMENT SCREENING FORM RAPID IMPACT ASSESSMENT SCREENING FORM Name of procedural document Wig Appliance Policy Directorate and Service Area Business and Finance Name, job title and contact details of person completing the assessment Sharon Collingwood, Health Records Manager Date: 18 November 2013 EXECUTIVE SUMMARY No Impacts identified 1. What is the main purpose of this policy / plan / service? To ensure that the provision of wigs by the RDE is managed fairly 2. Who does it affect? Please tick as appropriate. Carers Staff Patients Other (please specify) This Policy focuses mainly on patients. 3. What impact is it likely to have on different sections of the community / workforce, considering the protected characteristics below? Please insert a tick in the appropriate box Review date: November 2016 Page 12 of 14

Protected Characteristics Positive impact -- it could benefit Negative impact -- it treats them less favourably or could do Negative impact -- they could find it harder than others to benefit from it or they could be disadvantaged by it Non-impact missed opportunities to promote equality Neutral -- unlikely to have a specific effect Age Disability Sex including Transgender and Pregnancy / Maternity Race Religion / belief Sexual orientation including Marriage / Civil Partnership In identifying the impact of your policy across these characteristics, please consider the following issues: - Fairness - Does it treat everyone justly? - Respect - Does it respect everyone as a person? - Equality - Does it give everyone an equal chance to get whatever it is offering? - Dignity - Does it treat everyone with dignity? - Autonomy - Does it recognise everyone s freedom to make decisions for themselves? If you have any negative impacts, you will need to progress to a full impact assessment. In sections 4 and 5, please copy and repeat the tables below, for each protected characteristic considered. Alternatively, you can use one table for more than one protected characteristic, if the outcomes are similar. 4. If you have identified any positive impacts (see above), what will you do to make the most of them? Review date: November 2016 Page 13 of 14

Protected characteristic affected: Issue Who did you ask to understand the issues or whose work did you look at? What did you find out about? What did you learn or confirm? Action as a result of above Action By who? When? 5. If you have identified any missed opportunities ( non-impacts ), what will you do to take up any opportunities to promote equality? Protected characteristic affected: Issue Who did you ask to understand the issues or whose work did you look at? What did you find out about? What did you learn or confirm? Action as a result of above Action By who? When? 6. If you have a identified a neutral impact, show who you have consulted or asked to confirm that this is the case, in the table below: Who did you ask or consult to confirm your neutral impacts? (Please list groups or individuals below. These may be internal or external and should include the groups approving the policy.) Tony Williams, Equality and Diversity Manager Policy Expert Panel Cancer Patient Support Group If you need help with any aspect of this assessment, please contact: Tony Williams Equality and Diversity Manager Ext: 6942 anthony.williams1@nhs.net Please note: This impact assessment needs to be sent, with the policy, to the Equality & Diversity Manager at the following stages: as part of consultation, prior to final ratification of the policy and when final ratification has been given. Review date: November 2016 Page 14 of 14